Financials PT Medikaloka Hermina Tbk

Equities

HEAL

ID1000143100

Healthcare Facilities & Services

End-of-day quote INDONESIA S.E. 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
1,275 IDR -0.78% Intraday chart for PT Medikaloka Hermina Tbk +13.33% -14.43%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,06,43,340 1,04,59,390 1,57,01,180 2,24,17,924 2,16,92,778 1,89,26,562 - -
Enterprise Value (EV) 2 11,345 11,152 16,078 23,380 23,098 20,007 19,680 19,905
P/E ratio 42.3 x 22.6 x 15.9 x 75.4 x 50.1 x 32.5 x 26.5 x 24.6 x
Yield - 0.71% 0.56% 0.57% - 0.84% 1.04% 1.19%
Capitalization / Revenue 2.93 x 2.37 x 2.7 x 4.57 x 3.75 x 2.87 x 2.61 x 2.34 x
EV / Revenue 3.12 x 2.53 x 2.76 x 4.77 x 3.99 x 3.03 x 2.71 x 2.47 x
EV / EBITDA 13.1 x 8.04 x 7.26 x 20.5 x 15.8 x 10.7 x 9.43 x 8.18 x
EV / FCF -3,374 x 23.9 x 25 x -89.5 x -85 x -318 x 43.1 x 28.7 x
FCF Yield -0.03% 4.19% 4% -1.12% -1.18% -0.31% 2.32% 3.48%
Price to Book 4.96 x 4.09 x 4.87 x 6.52 x 5.61 x 4.43 x 3.77 x 3.56 x
Nbr of stocks (in thousands) 1,48,65,000 1,48,15,000 1,46,74,000 1,44,63,176 1,45,58,911 1,47,86,376 - -
Reference price 3 716.0 706.0 1,070 1,550 1,490 1,280 1,280 1,280
Announcement Date 05/04/20 17/05/21 31/03/22 31/03/23 28/03/24 - - -
1IDR in Million2IDR in Billions3IDR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,631 4,416 5,820 4,902 5,784 6,595 7,252 8,074
EBITDA 1 866.6 1,387 2,213 1,142 1,464 1,866 2,088 2,432
EBIT 1 583.3 1,042 1,778 587.4 818 1,008 1,230 1,345
Operating Margin 16.06% 23.59% 30.55% 11.98% 14.14% 15.29% 16.96% 16.65%
Earnings before Tax (EBT) 1 505.5 946 1,658 480.1 710.4 917.2 1,080 1,207
Net income 1 255.4 473.2 1,003 298.6 437.3 581.3 714.2 751
Net margin 7.03% 10.72% 17.24% 6.09% 7.56% 8.82% 9.85% 9.3%
EPS 2 16.92 31.18 67.28 20.57 29.73 39.36 48.33 52.00
Free Cash Flow 3 -3,362 4,66,723 6,42,792 -2,61,272 -2,71,707 -63,000 4,56,604 6,93,000
FCF margin -92.59% 10,568.81% 11,044.3% -5,330.11% -4,697.49% -955.31% 6,296.16% 8,583.37%
FCF Conversion (EBITDA) - 33,649.82% 29,040.59% - - - 21,871.64% 28,491.83%
FCF Conversion (Net income) - 98,626.65% 64,078.89% - - - 63,932.17% 92,276.96%
Dividend per Share 2 - 5.000 6.000 8.874 - 10.70 13.32 15.28
Announcement Date 05/04/20 17/05/21 31/03/22 31/03/23 28/03/24 - - -
1IDR in Billions2IDR3IDR in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2023 Q1 2023 Q3 2023 Q4
Net sales 1 1,193 - 1,538 1,554
EBITDA 469.1 - - -
EBIT 1 358.7 - - 178.6
Operating Margin 30.07% - - 11.49%
Earnings before Tax (EBT) 1 327.7 - - 150.2
Net income 1 230 108.9 - 88.51
Net margin 19.28% - - 5.69%
EPS - 7.490 - -
Dividend per Share - - - -
Announcement Date 31/03/22 25/04/23 18/10/23 28/03/24
1IDR in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 701 692 376 962 1,405 1,080 753 979
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.8094 x 0.4992 x 0.17 x 0.8426 x 0.9599 x 0.5788 x 0.3609 x 0.4024 x
Free Cash Flow 2 -3,362 4,66,723 6,42,792 -2,61,272 -2,71,707 -63,000 4,56,604 6,93,000
ROE (net income / shareholders' equity) 12.7% 20.1% 34.5% 8.1% 12% 13.5% 15.3% 15.1%
ROA (Net income/ Total Assets) 5.54% 8.3% 14.4% 5% 5.34% 7.62% 8% 6.6%
Assets 1 4,610 5,702 6,971 5,972 8,197 7,626 8,925 11,379
Book Value Per Share 3 144.0 172.0 220.0 238.0 266.0 289.0 339.0 359.0
Cash Flow per Share 3 37.90 74.20 125.0 59.80 89.70 109.0 107.0 136.0
Capex 1 576 890 1,214 1,129 1,591 1,013 953 -
Capex / Sales 15.86% 20.15% 20.85% 23.03% 27.51% 15.37% 13.14% -
Announcement Date 05/04/20 17/05/21 31/03/22 31/03/23 28/03/24 - - -
1IDR in Billions2IDR in Million3IDR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
1,280 IDR
Average target price
1,690 IDR
Spread / Average Target
+32.07%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. HEAL Stock
  4. Financials PT Medikaloka Hermina Tbk